Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nonoxynol 9 |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
Nonoxinol 125 mg/g vaginal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
Nonoxinol 20 mg/g vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
nonoxynol '9' 5 % vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
svangerskabsforebyggende svamp (p-pude) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
Contraceptive sponge NOS |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
nonoxynol-9, 1 g svangerskabsforebyggende svamp (p-pude) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
Allergy to nonoxinol (finding) |
Causative agent |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|
nonoxynol '9' 6 % vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nonoxinol 9 (substance) |
Inferred relationship |
Some |
|